Madhyastha H K, Radha K S, Sugiki M, Omura S, Maruyama M
Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, MIYAZAKI-889-1692, Japan.
Biochim Biophys Acta. 2006 Nov;1760(11):1624-30. doi: 10.1016/j.bbagen.2006.08.012. Epub 2006 Aug 24.
We have previously demonstrated the efficacy of c-phycocyanin in up-regulation of urokinase-type plasminogen activator (uPA) in bovine endothelial cell line. However, the mechanism of action and pathway elucidation in uPA regulation is unclear. In experiments reported here, we have investigated the mechanism of action of c-phycocyanin (c-pc) induced uPA gene modulation in human fibroblast (WI-38) cell line. ELISA test confirmed that c-pc increased the uPA antigen whereas PAI-1 antigen level was unaffected. Treatment of cells with c-pc significantly (P<0.05) enhanced the uPA mRNA level in a dose (50 microg/ml) and time dependent (up to 4 h) manner. This effect of c-pc was abolished by treatment with dichloro-1-beta-D-ribofuranosyl benzamidazole (DRB) (10 microg/ml). Co-treatment of c-pc with 200 microg/ml cycloheximide (CHX), translation inhibitor, resulted in over accumulation of uPA mRNA. These results suggest that uPA induction by c-pc is transcriptionally regulated and does not require de novo protein synthesis. We also provide evidence that c-pc stimulates uPA gene through cAMP dependent pathway as adenylyl cyclase (AC) inhibitor, dideoxyadenosine (DDA) significantly inhibited the uPA mRNA expression and co-treatment with adenylyl cyclase analogue, dBcAMP recovered the effect of c-pc on gene activity. Furthermore, the present investigation provides evidence on the regulatory pathway involved in the c-pc stimulus. C-pc induced uPA expression was completely inhibited by PKA inhibitor (KT 5200), indicating the regulation is dependent on PKA pathway. Elimination of PKC pathway components by prolonged incubation with excess amount of phorbol 12-myristate 13-acetate (PMA) failed to abolish the c-pc effect on uPA expression indicating the regulation is independent of PKC pathway. Taken together, our data indicate that uPA gene regulation by c-pc is transcriptionally controlled through cAMP mediated PKA pathway.
我们之前已经证明了藻蓝蛋白在牛内皮细胞系中上调尿激酶型纤溶酶原激活剂(uPA)的功效。然而,uPA调控中的作用机制和途径尚不清楚。在本文报道的实验中,我们研究了藻蓝蛋白(c-pc)诱导人成纤维细胞(WI-38)系中uPA基因调节的作用机制。酶联免疫吸附测定(ELISA)试验证实,c-pc增加了uPA抗原,而纤溶酶原激活物抑制因子-1(PAI-1)抗原水平未受影响。用c-pc处理细胞以剂量(50微克/毫升)和时间依赖性(长达4小时)的方式显著(P<0.05)提高了uPA信使核糖核酸(mRNA)水平。用二氯-1-β-D-呋喃核糖基苯甲酰胺(DRB)(10微克/毫升)处理消除了c-pc的这种作用。c-pc与200微克/毫升环己酰亚胺(CHX,翻译抑制剂)共同处理导致uPA mRNA过度积累。这些结果表明,c-pc诱导uPA是通过转录调控的,且不需要从头合成蛋白质。我们还提供证据表明,c-pc通过环磷酸腺苷(cAMP)依赖性途径刺激uPA基因,因为腺苷酸环化酶(AC)抑制剂双脱氧腺苷(DDA)显著抑制了uPA mRNA表达,而与腺苷酸环化酶类似物双丁酰环磷腺苷钙(dBcAMP)共同处理恢复了c-pc对基因活性的作用。此外,本研究提供了关于c-pc刺激所涉及的调控途径的证据。c-pc诱导的uPA表达被蛋白激酶A(PKA)抑制剂(KT 5200)完全抑制,表明该调控依赖于PKA途径。用过量佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)长时间孵育消除蛋白激酶C(PKC)途径成分未能消除c-pc对uPA表达的作用,表明该调控独立于PKC途径。综上所述,我们的数据表明,c-pc对uPA基因的调控是通过cAMP介导的PKA途径进行转录控制的。